From: Bacillus subtilis: a universal cell factory for industry, agriculture, biomaterials and medicine
Products | Strains | Characteristics | Titer | References |
---|---|---|---|---|
Riboflavin | B. subtilis 125 | The deregulation of the rib operon and purine de novo synthesis pathway | 4232 ± 34.42 mg/L | [50] |
Menaquinone-7 | B. subtilis 20-QT | Co-overexpression of tatAD-CD and qcrA-C | 410Â mg/L | [60] |
Scyllo-Inositol | B. subtilis KU303 | Deletion of iolABCDEF, iolHIJ, iolX and iolR, combined with the expression of IolG, IolW, IolT and PntAB | 27.6 g/L | [61] |
Hyaluronic acid | B. subtilis E168TH | Expression of hasA, tuaD, gtaB, glmU, glmM, glmS, and H6LHyal | 19.38Â g/ L | [64] |
N-acetylglucosamine | B. subtilis 168 BNDR122 | Deletion of nagP, gamP, gamA, gamR, nagA, nagB, ldh, alsRSD, pta, ackA, glcK, pckA, pyk, lacA and amyE, combined with the expression of GNAI | 131.6Â g/L | [67] |
Amorphadiene | B. subtilis 1A1 | Overexpression of dxs, idi and ads | 20Â mg/L | [96] |
Poly-γ-glutamic acid | B. subtilis ZJU − 7 | Optimizing culture conditions | 101.1 g/L | [97] |
Acetoin | B. subtilis CGMCC 13,141 | Deletion of araR, bdhA and acoA | 83.7 g/L | [98] |
Shikimate | B. subtilis 168 CLC6-PYKA | Deletion of pykA and aroI | 4.67Â g/L | [99] |
2,3-Butanediol | B. subtilis F9 | Deletion of upp, acoA, bdhA, pta, and ldh, combined with the expression of alsS, alsD, budC, and udhA | 103.7 g/L | [100] |
Isobutanol | B. subtilis UL08 | Deletion of alsS, ldh, pdhC and pgi, combined with the expression of zwf and udhA | 6.12Â g/L | [101] |
Chondroitin | B. subtilis E168H | Expression of kfoC-kfoA and kfiC-kfiA, combined with the upregulation of tuaD | 5.22Â g /L | [102] |
Heparosan | B. subtilis E168H | Expression of kfoC-kfoA and kfiC-kfiA, combined with the upregulation of tuaD | 5.82Â g/ L | [102] |